Trypsin CTRL

Our treatment solution for coronavirus is based on an oily inhalation that shifts the pH to the required value, preventing the entrance of the virus in the lung cells, by creating an unfavorable environment for the trypsin enzyme.

In our preliminary tests, we were able to change the pH of the inhaled air by using different types of natural substances. We would need resources to be able to process further testing as quickly as possible.

The solution could have a global market as the whole world is fighting against the spread of the virus these days. It is important that this could be a relatively cheap solution, with a low access barrier.

The coronavirus puts a huge strain on health systems globally. With our medical team, we have found a possible solution to treat the virus. The advantage of our solution is that it could be tested quickly without greater risk and could save a lot of lives.

Coronavirus enters lung cells through a receptor called ACE2.
The whole process requires the presence of the trypsin enzyme.
The function of the trypsin enzyme can be inhibited locally by shifting the pH of the lungs.
Our treatment solution is based on an oily inhalation that shifts the pH to the required value, preventing the entrance of the virus in the lung cells, by creating an unfavorable environment for trypsin. There are inexpensive inhalers that are currently used to inhale even at home. After a successful testing period, we could provide a solution that takes the burden of healthcare.

We are not aware of any competitors yet, it is still a blue ocean market.

With this solution we could skip the drug authorization process, there is no need to introduce a new medicament to the market. It is a relatively inexpensive solution, it could be standardized easily. Another advantage is that more people could heal from the virus without the need for a respirator.
The economy could also recover sooner if we found a solution soon to control the pandemic.

Reaching out to sponsors who have an interest in selling the inhaler.
Reaching out to sponsors who have an interest in selling the oils.
Reaching out to sponsors who have an interest in gaining PR presence.

The investment is needed for the development of the method and for clinical testing. Measurements are needed for the standardization process.

10 % share/ 30.000 Usd

Medication appears sooner than expected.